2-amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine,
BML-284,
Wnt Agonist,
853220-52-7,
2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine,
BML 284,
2-Amino-4-[3,4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl)pyrimidine,
SCHEMBL430891,
Wnt agonist 1(BML-284),
Wnt agonist 1 (BML-284),
CTK8G3784,
KS-00000HNX,
BML 284;BML284,
CHEBI:125559,
BCP17186,
EX-A2428,
HSCI1_000334,
IN1013,
ZINC44063027,
CCG-208089,
CS-5516,
NCGC00386697-01,
AK-37265,
HY-19987,
BRD-K42624714-001-01-7,
N4-(Benzo[d][1,3]dioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine,
N4-[(2H-1,3-benzodioxol-5-yl)methyl]-6-(3-methoxyphenyl)pyrimidine-2,4-diamine,
Wnt agonist 1,
681665? Wnt Agonist,
CID11210285,
A15851,
C581356,
N'-(benzo[1,3]dioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine,